These findings suggest that incorporating PAX1‐methylation detection into current cervical cancer‐screening protocols (Figure 1) will promote the accurate screening of women requiring treatment, reduce unnecessary referrals for colposcopy and biopsy, and ease the burden on patients and medical resources. The gene discussed is PAX1; the disease is cervical cancer.